Litcius/Paper detail

MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients

Mathilde Saint‐Ghislain, Anne‐Céline Derrien, Lionnel Geoffrois, Lauris Gastaud, Thierry Lesimple, Sylvie Négrier, Nicolas Penel, Jean‐Emmanuel Kurtz, Yannick Le Corre, Caroline Dutriaux, Sophie Gardrat, Raymond L. Barnhill, Alexandre Matet, Nathalie Cassoux, Alexandre Houy, Toulsie Ramtohul, Vincent Servois, Pascale Mariani, Sophie Piperno‐Neumann, Marc‐Henri Stern, Manuel Rodrigues

2022European Journal of Cancer37 citationsDOI

Topics & Concepts

OncologyMedicineInternal medicineRetrospective cohort studyMutationCancer researchBiologyGeneGeneticsOcular Oncology and TreatmentsMultiple and Secondary Primary CancersGlioma Diagnosis and Treatment
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients | Litcius